BRO vs TBPH · P/E 30, rev $3.58B vs P/E 7.5, rev $38.4M
Brown & Brown Inc (BRO) versus Theravance Biopharma Inc (TBPH) — a side-by-side from cached financials, not a winner call.
Brown & Brown Inc (BRO) is a insurance brokers company listed on US.
Theravance Biopharma Inc (TBPH) is a biotechnology company listed on NASDAQ.
Latest reported BRO revenue for 2026-06-30 was $3.58B. Net income was $714.0M. Revenue was up 88.2% from 2026-03-31 to 2026-06-30. BRO currently screens at market cap $35.56B and trailing P/E 30.0.
Latest reported TBPH revenue for 2026-06-30 was $38.4M. Net income was -$10.8M. TBPH currently screens at market cap $861.5M and trailing P/E 7.5.
BRO currently screens at market cap $35.56B and trailing P/E 30.0. TBPH currently screens at market cap $861.5M and trailing P/E 7.5.
Not investment advice. Open the BRO and TBPH stock pages for the full models.
Not investment advice.